Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
143.25
-0.38 (-0.26%)
Nov 13, 2024, 4:00 PM EST - Market closed
Glaukos Market Cap
Glaukos has a market cap or net worth of $7.89 billion as of November 13, 2024. Its market cap has increased by 142.85% in one year.
Market Cap
7.89B
Enterprise Value
7.81B
1-Year Change
142.85%
Ranking
Category
Stock Price
$143.25
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $7.89B, an increase of 689.76%. That is a compound annual growth rate of 24.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2024 | 7.92B | 104.16% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | -0.00% |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Ensign Group | 8.63B |
| Bruker | 8.59B |
| Henry Schein | 8.51B |
| Chemed | 8.39B |
| Walgreens Boots Alliance | 8.12B |
| Repligen | 7.81B |
| Halozyme Therapeutics | 7.77B |
| Jazz Pharmaceuticals | 7.68B |